OncoSec Medical Incorporated, based in Ewing Township, NJ, is a biotechnology company focused on developing innovative therapies for the treatment of cancer. Their lead product candidate, TAVO, utilizes intratumoral administration of IL-12 to stimulate a systemic immune response, offering a potential transformative therapy option for various cancers.
With a core technology platform that continues to advance through clinical trials, OncoSec is dedicated to arming the immune system to target and attack cancer cells. They have a track record of establishing successful partnerships globally and are committed to bringing new approaches and hope to patients through their investigational products.
Generated from the website